Regenerative Medical Technology (RMTG) Operating Margin (QoQ) (2018 - 2026)
Powered by 
Analysis
Regenerative Medical Technology (RMTG) Operating Margin (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn |
| 10 | Regenerative Medical Technology | 1.18 Mn | -139,694.93 | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 536.00 |
| Mar 31, 2026 | 2,819.00 |
| Dec 31, 2025 | 1,828.00 |
| Sep 30, 2025 | -1,233.00 |
| Jun 30, 2025 | -3,532.00 |
| Mar 31, 2025 | -1,530.00 |
| Dec 31, 2024 | 2,320.00 |
| Sep 30, 2024 | 2,896.00 |
| Jun 30, 2024 | -1,411.00 |
| Mar 31, 2024 | 908.00 |
| Dec 31, 2023 | -1,034.00 |
| Sep 30, 2023 | 10,762.00 |
| Jun 30, 2023 | -10,979.00 |
| Mar 31, 2023 | 42,449.00 |
| Dec 31, 2022 | -38,996.00 |
| Sep 30, 2022 | 7,892.00 |
| Jun 30, 2022 | 5,867.00 |
| Mar 31, 2022 | 1,500.00 |
| Dec 31, 2021 | 526,593.00 |
| Sep 30, 2021 | -384,849.00 |